Detecting ESR1 Mutations in Metastatic Breast Cancer: The Role of Liquid Biopsies
Charles Turck, PharmD, BCPS, BCCCP
Pavani Chalasani MD, MPH
Best Practices for Detecting ESR1 Mutations in Metastatic Breast Cancer
Stephanie Graff, MD
ESR1 Mutations in Metastatic Breast Cancer: A Predictor of Poor Prognosis
Marcela Mazo Canola, MD
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
Mariya Rozenblit, MD
How Testing for Acquired vs. Intrinsic Mutations in HR+/HER2- Metastatic Breast Cancer Differs
Megan Kruse, MD
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
Ezra Cohen, MD
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Deborah J. Wong, MD, PhD
How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis
Stacy Walker, NP
What Can I Do to Improve Care of Prostate Cancer Patients at Risk for Inequities?
Kelvin A. Moses, MD, PhD, FACS
Intensifying ADT in mHSPC: How to Improve Patient Outcomes and Adherence
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP
Alicia K. Morgans, MD, MPH
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Terran Sims, MSN, ACNP-C, CNN, COCN-C
Laura M. Spring, MD
Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer
Sarah Traverso, MMS, PA-C
Biomarker Testing in NSCLC: Who, What, When?
Rasheda Persinger MSN, AGNP-C, AOCNP
Highlights from Singapore on Immunotherapies in Early-Stage NSCLC
Charu Aggarwal, MD, MPH
Patrick Forde, M.B.B.Ch.
Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
Mary Weinstein Dunn
The Role of PARP Inhibitors in Metastatic Breast Cancer
Multiple Myeloma At First Relapse: Is My Patient Refractory to Lenalidomide?
Noa Biran, MD
Loading...
Stay current with the best on medical education
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
